Orexin B, human is an endogenous agonist at Orexin receptor with Kis of 420 and 36 nM for OX1 and OX2, respectively.
CAT No: 10-101-319
CAS No:205640-91-1
Synonyms/Alias:Orexin B (human);205640-91-1;Orexin B, human TFA;Human orexin B TFA;(Met-28 = C-terminal amide);RSGPPGLQGRLQRLLQASGNHAAGILTM;C123H212N44O35S;HB5323;AKOS024456609;Orexin B (human) trifluoroacetate salt;FO109202;PD079176;H-Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala -Gly-Ile-Leu-Thr-Met-NH2; H-RSGPPGLQGR LQRLLQASGNHAAGILTM-NH2;
2. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
4. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
5. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.